Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the Wall Street Journal reporter who has been investigating the firm’s collapse.
Sep 16
How to Be a Double Unicorn, with John Urschel | Better in Person
He was thriving in the N.F.L., but then he decided to focus on mathematics — a subject he now teaches at M.I.T. John walks Stephen Dubner through the whole story, teaches him some blocking techniques, and explains why some infinities are bigger than others. If you'd like to see t ... Show More
32m 32s
Sep 11
686. Why Is It So Hard to Find an NFL Quarterback?
For decades, teams have tried (and mostly failed) to predict which college quarterbacks will thrive in the pros. Is the science finally catching up? Stephen Dubner speaks with a scout, a psychologist, a data warrior, and a Hall of Fame quarterback who nobody wanted. SOURCES:Scott ... Show More
58m 20s
Aug 2024
How 23andMe went from a $6 billion valuation to trading for pennies
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More
54m 45s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s